United Arab Emirates Gene Synthesis Research Use Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

The UAE Gene Synthesis Research Use Market, worth USD 6 million, grows via innovations in precision medicine, gene editing, and key hubs in Dubai and Abu Dhabi.

Region:Middle East

Author(s):Geetanshi

Product Code:KRAA4143

Pages:86

Published On:January 2026

About the Report

Base Year 2024

United Arab Emirates Gene Synthesis Research Use Market Overview

  • The United Arab Emirates Gene Synthesis Research Use Market is valued at USD 6 million, based on a five-year historical analysis and considering its share within the regional DNA and gene synthesis markets. This growth is primarily driven by advancements in biotechnology, increasing investments in research and development, and a growing demand for synthetic biology applications across sectors such as healthcare, precision medicine, agriculture, and industrial biotechnology.
  • Key cities dominating this market include Dubai and Abu Dhabi, which are recognized for their robust infrastructure, access to cutting-edge research facilities, and a favorable regulatory and investment environment for life sciences. Dubai Healthcare City, Dubai Science Park, Mohammed Bin Rashid University of Medicine and Health Sciences, and Abu Dhabi’s Khalifa University and Masdar City innovation cluster attract both local and international biotech firms, fostering innovation and collaboration in gene synthesis and broader genomic technologies.
  • In 2023, the UAE government implemented a new regulation aimed at enhancing the biotechnology sector, which includes a framework for the ethical use of gene synthesis technologies. This regulation aligns with instruments such as the Federal Decree-Law No. 10 of 2015 on the Safety of Biological Agents and their Related Supplies issued by the UAE Federal Government, which sets requirements for handling, importing, and using biological materials, including genetically modified and synthetic genetic constructs, in line with international biosafety and biosecurity standards. The framework mandates institutional ethics oversight, biosafety risk assessment, and adherence to international best practices, promoting transparency in research practices and encouraging investment and growth in the gene synthesis market.
United Arab Emirates Gene Synthesis Research Use Market Size

United Arab Emirates Gene Synthesis Research Use Market Segmentation

By Product & Service:The product and service segmentation of the market includes various offerings that cater to the diverse needs of researchers and organizations involved in gene synthesis. The dominant sub-segment is Gene Synthesis Services, which is preferred due to its ability to provide customized solutions for complex genetic constructs and the limited in?house synthesis capacity at many regional laboratories. This is followed by Gene Synthesis Kits & Reagents, which are essential for laboratory workflows involving PCR, cloning, and DNA assembly. The demand for Oligonucleotide Synthesis is also significant, driven by its applications in diagnostics, qPCR, next-generation sequencing workflows, and therapeutics research. Cloning & Assembly Services are gaining traction as researchers seek efficient methods for gene manipulation, plasmid construction, and pathway engineering, often via outsourced service providers. Other services, such as related bioinformatics support and design tools, complement these primary offerings and support end users in academia, hospitals, and industry.

United Arab Emirates Gene Synthesis Research Use Market segmentation by Product & Service.

By Gene Type:The gene type segmentation includes various categories that cater to specific research needs. Standard Genes are the most widely used due to their broad applications in basic research, expression studies, and educational settings. Complex & GC-rich Genes are gaining popularity as researchers explore more intricate genetic constructs, including challenging templates for structural biology, enzyme engineering, and pathway optimization. Customized Gene Fragments are increasingly in demand for tailored research projects, modular cloning, and rapid prototyping of constructs, while Synthetic Gene Libraries are utilized for high-throughput screening, protein engineering, and directed evolution. Other gene types, including regulatory sequences and non-coding constructs, also play a role in niche applications within genomics and synthetic biology.

United Arab Emirates Gene Synthesis Research Use Market segmentation by Gene Type.

United Arab Emirates Gene Synthesis Research Use Market Competitive Landscape

The United Arab Emirates Gene Synthesis Research Use Market is characterized by a dynamic mix of regional and international players. Leading participants such as Thermo Fisher Scientific Inc., Integrated DNA Technologies, Inc. (IDT), GenScript Biotech Corporation, Eurofins Genomics, Twist Bioscience Corporation, Precigen, Inc. (formerly Synthetic Genomics), Bio Basic Inc., Bioneer Corporation, ATUM, Codex DNA, Inc. (formerly DNA2.0), LGC Biosearch Technologies (LGC Group), GeneArt Gene Synthesis (Thermo Fisher Scientific), Jena Bioscience GmbH, Genomatix Software GmbH, Other Emerging Regional & Global Players contribute to innovation, geographic expansion, and service delivery in this space, often serving UAE customers through regional distribution partners, online ordering platforms, and collaborations with local research institutions.

Thermo Fisher Scientific Inc.

1956

Waltham, Massachusetts, USA

Integrated DNA Technologies, Inc. (IDT)

1987

Coralville, Iowa, USA

GenScript Biotech Corporation

2002

Nanjing, China

Eurofins Genomics

1987

Ebersberg, Germany

Twist Bioscience Corporation

2013

San Francisco, California, USA

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

UAE Gene Synthesis Revenue (USD, Latest Year)

3-year UAE Revenue CAGR

Share of Revenue from Research-use-only Gene Synthesis (%)

Average Order Value per Research Customer (USD)

Number of Active Research Customers in UAE

United Arab Emirates Gene Synthesis Research Use Market Industry Analysis

Growth Drivers

  • Increasing Demand for Synthetic Biology Applications:The United Arab Emirates has seen a surge in synthetic biology applications, with the biotechnology sector projected to contribute approximatelyto the economy in future. This growth is driven by the rising need for innovative solutions in healthcare, agriculture, and environmental sustainability. The UAE's strategic initiatives, such as the National Biotechnology Strategy, aim to enhance research capabilities, further fueling demand for gene synthesis technologies.
  • Advancements in Gene Editing Technologies:The rapid evolution of gene editing technologies, particularly CRISPR, has significantly impacted the UAE's gene synthesis market. In future, investments in gene editing research are expected to exceed, reflecting a growing interest in precision medicine and agricultural biotechnology. These advancements enable researchers to develop more effective therapies and genetically modified organisms, driving the demand for gene synthesis services and products.
  • Rising Investments in Biotechnology Research:The UAE government has committed overto biotechnology research and development initiatives, aiming to position the country as a regional hub for biotech innovation. This funding supports academic institutions and private enterprises, fostering collaborations that enhance gene synthesis capabilities. As a result, the market is witnessing increased activity, with more research projects focusing on gene synthesis applications in various sectors, including healthcare and agriculture.

Market Challenges

  • Regulatory Hurdles in Biotechnology:The gene synthesis market in the UAE faces significant regulatory challenges, with stringent guidelines governing genetic research and biotechnology applications. Compliance with these regulations can be costly and time-consuming, potentially hindering innovation. In future, it is estimated that regulatory compliance costs could account for up toof total operational expenses for biotech firms, impacting their ability to invest in research and development.
  • Limited Awareness Among End-Users:Despite the advancements in gene synthesis technologies, there remains a notable gap in awareness among potential end-users, including researchers and healthcare professionals. A survey indicated that onlyof researchers in the UAE were familiar with the latest gene synthesis techniques. This lack of awareness can limit market growth, as potential users may not fully understand the benefits and applications of these technologies in their fields.

United Arab Emirates Gene Synthesis Research Use Market Future Outlook

The future of the gene synthesis market in the UAE appears promising, driven by ongoing advancements in biotechnology and increasing government support. As the demand for personalized medicine and innovative agricultural solutions rises, the market is expected to expand significantly in future. Collaborations between research institutions and private companies will likely enhance the development of cost-effective synthesis methods, while the integration of artificial intelligence in gene synthesis processes will streamline operations and improve outcomes, positioning the UAE as a leader in this field.

Market Opportunities

  • Expansion of Research Institutions:The establishment of new research institutions in the UAE presents a significant opportunity for the gene synthesis market. With overnew biotech research centers expected to open in future, these institutions will drive demand for gene synthesis services, fostering innovation and collaboration in the sector.
  • Collaborations with Pharmaceutical Companies:Strategic partnerships between biotech firms and pharmaceutical companies are on the rise, creating opportunities for gene synthesis providers. In future, collaborations are projected to increase by, enabling the development of novel therapies and enhancing the overall market landscape through shared resources and expertise.

Scope of the Report

SegmentSub-Segments
By Product & Service

Gene Synthesis Services

Gene Synthesis Kits & Reagents

Oligonucleotide Synthesis

Cloning & Assembly Services

Others

By Gene Type

Standard Genes

Complex & GC?rich Genes

Customized Gene Fragments

Synthetic Gene Libraries

Others

By Application (Research Use Only)

Synthetic Biology & Metabolic Engineering

Genetic Engineering & Cloning

Vaccine & Therapeutics R&D

Diagnostics & Assay Development

CRISPR & Genome Editing Research

Others

By End-User

Academic & Research Institutes

Biopharmaceutical & Diagnostics Companies

Contract Research Organizations (CROs)

Government & Non?profit Research Centers

Others

By Mode

Contract / Outsourced

In?house

By Region

Abu Dhabi

Dubai

Sharjah

Northern Emirates

Free Zones (Science & Technology Parks)

By Funding Source (Research Use Only)

Government Grants & National Programs

University & Institutional Budgets

Corporate & Industrial R&D Funding

Venture Capital & Private Investments

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Health and Prevention, Federal Authority for Nuclear Regulation)

Biotechnology and Pharmaceutical Companies

Research and Development Organizations

Healthcare Providers and Institutions

Biomanufacturing Firms

Contract Research Organizations (CROs)

Biotechnology Industry Associations

Players Mentioned in the Report:

Thermo Fisher Scientific Inc.

Integrated DNA Technologies, Inc. (IDT)

GenScript Biotech Corporation

Eurofins Genomics

Twist Bioscience Corporation

Precigen, Inc. (formerly Synthetic Genomics)

Bio Basic Inc.

Bioneer Corporation

ATUM

Codex DNA, Inc. (formerly DNA2.0)

LGC Biosearch Technologies (LGC Group)

GeneArt Gene Synthesis (Thermo Fisher Scientific)

Jena Bioscience GmbH

Genomatix Software GmbH

Other Emerging Regional & Global Players

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. United Arab Emirates Gene Synthesis Research Use Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 United Arab Emirates Gene Synthesis Research Use Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. United Arab Emirates Gene Synthesis Research Use Market Analysis

3.1 Growth Drivers

3.1.1 Increasing demand for synthetic biology applications
3.1.2 Advancements in gene editing technologies
3.1.3 Rising investments in biotechnology research
3.1.4 Growing focus on personalized medicine

3.2 Market Challenges

3.2.2 Regulatory hurdles in biotechnology
3.2.3 Limited awareness among end-users
3.2.4 Competition from established players

3.3 Market Opportunities

3.3.1 Expansion of research institutions
3.3.2 Collaborations with pharmaceutical companies
3.3.3 Development of cost-effective synthesis methods
3.3.4 Increasing government funding for biotech research

3.4 Market Trends

3.4.1 Rise of CRISPR technology
3.4.2 Growth in synthetic gene circuits
3.4.3 Increasing use of AI in gene synthesis
3.4.4 Focus on sustainable biotechnology solutions

3.5 Government Regulation

3.5.1 Guidelines for genetic research
3.5.2 Compliance requirements for biotech firms
3.5.3 Intellectual property regulations
3.5.4 Ethical considerations in gene editing

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. United Arab Emirates Gene Synthesis Research Use Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. United Arab Emirates Gene Synthesis Research Use Market Segmentation

8.1 By Product & Service

8.1.1 Gene Synthesis Services
8.1.2 Gene Synthesis Kits & Reagents
8.1.3 Oligonucleotide Synthesis
8.1.4 Cloning & Assembly Services
8.1.5 Others

8.2 By Gene Type

8.2.1 Standard Genes
8.2.2 Complex & GC?rich Genes
8.2.3 Customized Gene Fragments
8.2.4 Synthetic Gene Libraries
8.2.5 Others

8.3 By Application (Research Use Only)

8.3.1 Synthetic Biology & Metabolic Engineering
8.3.2 Genetic Engineering & Cloning
8.3.3 Vaccine & Therapeutics R&D
8.3.4 Diagnostics & Assay Development
8.3.5 CRISPR & Genome Editing Research
8.3.6 Others

8.4 By End-User

8.4.1 Academic & Research Institutes
8.4.2 Biopharmaceutical & Diagnostics Companies
8.4.3 Contract Research Organizations (CROs)
8.4.4 Government & Non?profit Research Centers
8.4.5 Others

8.5 By Mode

8.5.1 Contract / Outsourced
8.5.2 In?house

8.6 By Region

8.6.1 Abu Dhabi
8.6.2 Dubai
8.6.3 Sharjah
8.6.4 Northern Emirates
8.6.5 Free Zones (Science & Technology Parks)

8.7 By Funding Source (Research Use Only)

8.7.1 Government Grants & National Programs
8.7.2 University & Institutional Budgets
8.7.3 Corporate & Industrial R&D Funding
8.7.4 Venture Capital & Private Investments
8.7.5 Others

9. United Arab Emirates Gene Synthesis Research Use Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 UAE Gene Synthesis Revenue (USD, Latest Year)
9.2.4 3-year UAE Revenue CAGR
9.2.5 Share of Revenue from Research-use-only Gene Synthesis (%)
9.2.6 Average Order Value per Research Customer (USD)
9.2.7 Number of Active Research Customers in UAE
9.2.8 Customer Retention Rate (%)
9.2.9 On?time Delivery Rate (%)
9.2.10 Average Turnaround Time for Standard Gene Synthesis (days)
9.2.11 R&D Spend as % of Global Revenue
9.2.12 Number of Patents / IP Filings Related to Gene Synthesis
9.2.13 Local Presence (Offices / Distributors / Labs Count)
9.2.14 Compliance & Certifications (ISO, CAP, etc.)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Thermo Fisher Scientific Inc.
9.5.2 Integrated DNA Technologies, Inc. (IDT)
9.5.3 GenScript Biotech Corporation
9.5.4 Eurofins Genomics
9.5.5 Twist Bioscience Corporation
9.5.6 Precigen, Inc. (formerly Synthetic Genomics)
9.5.7 Bio Basic Inc.
9.5.8 Bioneer Corporation
9.5.9 ATUM
9.5.10 Codex DNA, Inc. (formerly DNA2.0)
9.5.11 LGC Biosearch Technologies (LGC Group)
9.5.12 GeneArt Gene Synthesis (Thermo Fisher Scientific)
9.5.13 Jena Bioscience GmbH
9.5.14 Genomatix Software GmbH
9.5.15 Other Emerging Regional & Global Players

10. United Arab Emirates Gene Synthesis Research Use Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation Trends
10.1.2 Decision-Making Processes
10.1.3 Preferred Suppliers
10.1.4 Compliance Requirements

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment Trends
10.2.2 Funding Sources
10.2.3 Project Prioritization
10.2.4 Cost Management Strategies

10.3 Pain Point Analysis by End-User Category

10.3.1 Research Institutions
10.3.2 Pharmaceutical Companies
10.3.3 Biotech Firms
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Training Needs
10.4.2 Technology Adoption Barriers
10.4.3 Support Requirements
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Performance Metrics
10.5.2 User Feedback Mechanisms
10.5.3 Future Investment Plans
10.5.4 Others

11. United Arab Emirates Gene Synthesis Research Use Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Value Proposition Development

1.3 Revenue Model Structuring

1.4 Key Partnerships

1.5 Customer Segmentation

1.6 Cost Structure Analysis

1.7 Competitive Advantage


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs

2.3 Target Market Identification

2.4 Communication Strategy

2.5 Digital Marketing Approaches

2.6 Event Marketing

2.7 Customer Engagement Tactics


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-ups

3.3 Online Distribution Channels

3.4 Direct Sales Approaches

3.5 Partnership with Distributors

3.6 Logistics and Supply Chain Management

3.7 Inventory Management


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands Analysis

4.3 Competitor Pricing Strategies

4.4 Customer Price Sensitivity

4.5 Value-Based Pricing

4.6 Discount Strategies

4.7 Bundling Opportunities


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments

5.3 Product Development Opportunities

5.4 Service Gaps

5.5 Market Entry Opportunities

5.6 Innovation Needs

5.7 Customer Feedback Analysis


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service

6.3 Customer Support Strategies

6.4 Feedback Mechanisms

6.5 Community Engagement

6.6 Relationship Management Tools

6.7 Customer Retention Strategies


7. Value Proposition

7.1 Sustainability Initiatives

7.2 Integrated Supply Chains

7.3 Unique Selling Points

7.4 Customer-Centric Approaches

7.5 Competitive Differentiation

7.6 Value Delivery Mechanisms

7.7 Brand Positioning


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding Initiatives

8.3 Distribution Setup

8.4 Market Research Activities

8.5 Training and Development

8.6 Performance Monitoring

8.7 Stakeholder Engagement


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model

10.5 Risk Assessment

10.6 Market Adaptation Strategies

10.7 Exit Strategies


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines

11.3 Funding Sources

11.4 Financial Projections

11.5 Budget Allocation

11.6 Cost-Benefit Analysis

11.7 Investment Risks


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships

12.2 Risk Mitigation Strategies

12.3 Control Mechanisms

12.4 Performance Monitoring

12.5 Decision-Making Frameworks

12.6 Stakeholder Management

12.7 Exit Strategies


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability

13.3 Profit Margin Projections

13.4 Revenue Growth Strategies

13.5 Cost Management Approaches

13.6 Financial Health Indicators

13.7 Investment Returns


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets

14.4 Strategic Alliances

14.5 Research Collaborations

14.6 Technology Partners

14.7 Funding Partners


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Activity Planning
15.2.2 Milestone Tracking
15.2.3 Performance Evaluation
15.2.4 Resource Allocation

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of market reports from biotechnology and life sciences associations in the UAE
  • Review of academic publications and patents related to gene synthesis technologies
  • Examination of government publications and regulatory frameworks affecting gene synthesis

Primary Research

  • Interviews with R&D directors at leading biotechnology firms in the UAE
  • Surveys targeting laboratory managers and procurement specialists in academic institutions
  • Field interviews with key opinion leaders in the gene synthesis domain

Validation & Triangulation

  • Cross-validation of findings through multiple data sources including industry reports and expert opinions
  • Triangulation of market trends with historical data and future projections
  • Sanity checks conducted through expert panel discussions and feedback sessions

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the gene synthesis market size based on national biotechnology spending
  • Segmentation of the market by application areas such as pharmaceuticals, agriculture, and research
  • Incorporation of growth rates from related sectors and emerging technologies

Bottom-up Modeling

  • Collection of data on gene synthesis service pricing from leading providers
  • Volume estimates based on laboratory usage and project demand across sectors
  • Cost analysis derived from operational expenses and service delivery models

Forecasting & Scenario Analysis

  • Multi-variable forecasting using trends in personalized medicine and synthetic biology
  • Scenario analysis based on regulatory changes and technological advancements
  • Development of baseline, optimistic, and pessimistic market projections through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Pharmaceutical Applications100R&D Directors, Product Development Managers
Agricultural Biotechnology80Research Scientists, Agronomists
Academic Research Institutions70Laboratory Managers, Principal Investigators
Clinical Research Organizations60Clinical Project Managers, Regulatory Affairs Specialists
Startups in Synthetic Biology50Founders, Technical Leads

Frequently Asked Questions

What is the current value of the United Arab Emirates Gene Synthesis Research Use Market?

The United Arab Emirates Gene Synthesis Research Use Market is valued at approximately USD 6 million, reflecting its growth driven by advancements in biotechnology and increasing investments in research and development across various sectors.

Which cities are key players in the UAE Gene Synthesis Market?

What are the main drivers of growth in the UAE Gene Synthesis Market?

What regulatory changes have impacted the UAE Gene Synthesis Market?

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022